简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
ClinicalTrialApproval
SIMCERE PHARMA(02096.HK): PD-1/VEGF Bispecific Antibody SIM0689 Approved for Clinical Trials by NMPA
Tags：
SIMCERE PHARMA
02096.HK
ClinicalTrialApproval
2026-06-12
Mabwell-B (02493.HK): 6MW5311 Injection Receives FDA Clinical Trial Approval as World’s First LILRB4/CD3-Targeted TCE Innovative Drug
Tags：
MABWELL-B
02493.HK
ClinicalTrialApproval
2026-06-12
SIMCERE PHARMA (02096.HK): SIM0613 (LRRC15 ADC) Receives NMPA Clinical Trial Approval
Tags：
SIMCERE PHARMA
02096.HK
ClinicalTrialApproval
2026-05-06
CSPC PHARMA(01093.HK): Antibody-Drug Conjugate SYS6051 Approved for Clinical Trials for Advanced Solid Tumors
Tags：
CSPC PHARMA
01093.HK
ClinicalTrialApproval
2026-04-15
Featured News
Finance
Fosun Pharma (02196.HK): DM1001 Preparation Obtains Clinical Trial Approval
Finance
China Financial Services(00605.HK): Grants RMB 8.9 Million Loan to Client
Finance
Yue Yuen Industrial(00551.HK): Profit Warning – Interim Profit Expected to Slump 55% to 60%
Finance
Huadian Power International(01071.HK): Power Generation Volume Hits Around 108 Million MWh in H1 2026, Down 10.65% Year-on-Year
Finance
OCI International(00329.HK): Change of Company Secretary, Authorised Representative and Process Agent
Research
Autonomous Driving Concept Stocks Watch | BIDU-SW(09888.HK) Trades Weakly in Afternoon; Apollo Go Secures Hong Kong Autonomous Driving Test License
ETF
Hsi Esg Enhanced Select Index Etf(03136.HK) Falls 1.21% Intraday, Average Trading Price at HK$13.130
ETF
Csop Msci Hk China Connect Select Etf(03432.HK) Drops 1.08% Intraday to HK$100.90
ETF
Hang Seng S&P 500 Index ETF (Listed Class)(03195.HK) Falls 0.68% Intraday, NAV Per Unit at HK$11.713
ETF
Global X Gold Covered Call Active Etf(03533.HK) Slips 0.42% Intraday to HK$70.74
Scan QR Code
Download App
